|
US4112085A
(en)
*
|
1974-10-28 |
1978-09-05 |
Morelle Jean V |
Metallic compositions
|
|
US4053589A
(en)
*
|
1975-11-24 |
1977-10-11 |
Control Drug Inc. |
Method of treating nutritional deficiency during cardiac cachexia, diabetes, hypoglycemia, gastroenterology, lipid, cell glycogen and keratin-related skin conditions and alcoholism
|
|
US4042688A
(en)
*
|
1975-11-24 |
1977-08-16 |
Control Drug, Inc. |
Method of providing high-protein nutrition by the oral administration of a predigested protein composition
|
|
US4042687A
(en)
*
|
1975-11-24 |
1977-08-16 |
Control Drug, Inc. |
Method of treating obesity by the oral administration of a predigested protein composition
|
|
DE2636828A1
(de)
*
|
1976-08-16 |
1978-02-23 |
Fresenius Chem Pharm Ind |
L-amonosaeurengemische fuer die behandlung von leberinsuffizienz sowie die herstellung derartiger gemische
|
|
DE2642768A1
(de)
*
|
1976-09-23 |
1978-03-30 |
Fresenius Chem Pharm Ind |
Essentielle und nicht essentielle l-aminosaeuren enthaltendes gemisch zur behandlung von leberinsuffizienz
|
|
DE2750159C3
(de)
*
|
1977-11-09 |
1980-05-22 |
Lentia Gmbh, Chem. U. Pharm. Erzeugnisse - Industriebedarf, 8000 Muenchen |
Infusionslösung zur Behandlung von hepatischer Encephalopathie und ein Verfahren zu deren Herstellung
|
|
US4320146A
(en)
*
|
1978-03-17 |
1982-03-16 |
The Johns Hopkins University |
Treatment of hepatic and renal disorders with ornithine and arginine salts of branched chain keto acids
|
|
US4228099A
(en)
*
|
1978-03-17 |
1980-10-14 |
The Johns Hopkins University |
Ornithine and arginine salts of branched chain keto acids and uses in treatment of hepatic and renal disorders
|
|
US4210637A
(en)
*
|
1978-07-31 |
1980-07-01 |
Massachusetts Institute Of Technology |
Composition and method for suppressing appetite for calories as carbohydrates
|
|
JPS5536457A
(en)
*
|
1978-09-08 |
1980-03-14 |
Ajinomoto Co Inc |
Amino acid infusion
|
|
IT1100677B
(it)
*
|
1978-11-03 |
1985-09-28 |
Boehringer Biochemia Srl |
Formazione farmaceutica iniettabile a base di amminoacidi
|
|
JPS568312A
(en)
*
|
1979-07-03 |
1981-01-28 |
Otsuka Pharmaceut Factory Inc |
Amino acid pharmaceutical preparation
|
|
JPS5668374A
(en)
*
|
1979-11-08 |
1981-06-09 |
Jun Sawada |
Food composition for hepatic insufficiency
|
|
DE2946563C2
(de)
*
|
1979-11-17 |
1987-04-30 |
B. Braun Melsungen Ag, 3508 Melsungen |
Aminosäurelösung zur parenteralen Infusion
|
|
DE3026368A1
(de)
*
|
1980-07-11 |
1982-02-18 |
Lentia GmbH Chem. u. pharm. Erzeugnisse - Industriebedarf, 8000 München |
Naehrloesung fuer die vollstaendige parenterale ernaehrung und fuer gesteigerte energieproduktion
|
|
US4438144A
(en)
|
1980-07-31 |
1984-03-20 |
Blackburn George L |
Amino acid preparation and therapy for treatment of stress and injury
|
|
US4574085A
(en)
*
|
1981-05-15 |
1986-03-04 |
Baxter Travenol Laboratories, Inc. |
Method for using dialysis solution containing glycerol
|
|
CA1184499A
(en)
*
|
1981-06-29 |
1985-03-26 |
David C. Madsen |
Nutritional composition for management of hepatic failure
|
|
US4898879A
(en)
*
|
1981-06-29 |
1990-02-06 |
Baxter International Inc. |
Nurtitional composition for management of hepatic failure
|
|
JPS5835685U
(ja)
*
|
1981-08-31 |
1983-03-08 |
三菱電機株式会社 |
電動圧縮機の支持装置
|
|
JPS5856177U
(ja)
*
|
1981-10-13 |
1983-04-16 |
ダイキン工業株式会社 |
圧縮機の取付装置
|
|
JPS58126767A
(ja)
*
|
1982-01-22 |
1983-07-28 |
Ajinomoto Co Inc |
肝臓病患者用栄養組成物
|
|
US4497800A
(en)
*
|
1982-07-06 |
1985-02-05 |
Mead Johnson & Company |
Stable liquid diet composition
|
|
JPS5916817A
(ja)
*
|
1982-07-16 |
1984-01-28 |
Eisai Co Ltd |
アミノ酸輸液
|
|
FR2556594B1
(fr)
*
|
1983-12-20 |
1988-09-09 |
Synthelabo |
Solutions d'acides amines
|
|
JPS6150917A
(ja)
*
|
1984-08-20 |
1986-03-13 |
Ajinomoto Co Inc |
抗アルコ−ル性肝障害組成物
|
|
US4687782A
(en)
*
|
1984-12-10 |
1987-08-18 |
Nutri-Fuels Systems, Inc. |
Nutritional composition for enhancing skeletal muscle adaptation to exercise training
|
|
US5397803A
(en)
*
|
1985-09-12 |
1995-03-14 |
Brigham And Women's Hospital |
Use of glutamine to reduce rate of pathogenic microorganism infection
|
|
US5763485A
(en)
*
|
1985-09-12 |
1998-06-09 |
Brigham And Women's Hospital |
Method of treating catabolic, gut-associated pathological processes and impaired host defenses
|
|
US4857555A
(en)
*
|
1985-09-12 |
1989-08-15 |
Brigham & Women's Hospital |
Method of treating catabolic dysfunction
|
|
US5684045A
(en)
*
|
1985-09-12 |
1997-11-04 |
Brigham And Women's Hospital |
Method of treating pancreatic atrophy
|
|
US5039704A
(en)
*
|
1985-09-12 |
1991-08-13 |
Brigham And Women's Hospital |
Method of treating catabolic dysfunction
|
|
JPH0667831B2
(ja)
*
|
1986-01-13 |
1994-08-31 |
森永乳業株式会社 |
肝物質合成機能障害改善用のアミノ酸組成物
|
|
US4859452A
(en)
*
|
1986-01-17 |
1989-08-22 |
Board Of Regents, The University Of Texas System |
Methods for the reduction of difluoromethylornithine associated toxicity
|
|
US5162373A
(en)
*
|
1986-01-17 |
1992-11-10 |
Board Of Regents, The University Of Texas System |
Methods and improved formulations for the determination and treatment of malignant disease in patients
|
|
JP2599593B2
(ja)
*
|
1986-06-26 |
1997-04-09 |
株式会社 大塚製薬工場 |
腎不全用アミノ酸輸液
|
|
JPS6314728A
(ja)
*
|
1986-07-03 |
1988-01-21 |
Zeria Shinyaku Kogyo Kk |
肝障害の予防、治療剤
|
|
US5032608A
(en)
*
|
1986-09-10 |
1991-07-16 |
Dudrick Stanley J |
Method and substrate composition for treating atherosclerosis
|
|
US5248688A
(en)
*
|
1986-09-10 |
1993-09-28 |
Dudrick Medical Research Fund I, Ltd. |
Method and substrate composition for treating atherosclerosis
|
|
GB2199243A
(en)
*
|
1986-09-17 |
1988-07-06 |
Natural Vitality Ltd |
Pharmaceutical compositions comprising ornithine and arginine
|
|
US4857320A
(en)
*
|
1987-02-19 |
1989-08-15 |
Monsanto Company |
Method of enhancing the solubility of tissue plasminogen activator
|
|
AU1942488A
(en)
*
|
1987-05-22 |
1988-12-21 |
Ab Pripps Bryggerier |
Use of amino acids for the preparation of a beverage
|
|
US5639731A
(en)
*
|
1987-05-22 |
1997-06-17 |
Pripps Bryggerier Ab |
Amino acids for the preparation of a beverage
|
|
US4868114A
(en)
*
|
1987-08-05 |
1989-09-19 |
Regents Of The University Of Minnesota |
Method for elevating glutathione levels
|
|
JPH0277550A
(ja)
*
|
1988-09-12 |
1990-03-16 |
Furukawa Alum Co Ltd |
成形加工用快削アルミニウム合金とその製造方法
|
|
US5189025A
(en)
*
|
1988-12-09 |
1993-02-23 |
Board Of Regenets, The University Of Texas System |
Methods for the treatment of malignant disease in patients using citrulline containing amino acid solutions
|
|
US4988724A
(en)
*
|
1988-12-09 |
1991-01-29 |
Board Of Regents, The University Of Texas System |
Methods and improved formulations for the determination and treatment of malignant disease in patients
|
|
DE3916903A1
(de)
*
|
1989-05-24 |
1991-02-28 |
Leopold Pharma Gmbh |
Waessrige zusammensetzung fuer die parenterale ernaehrung
|
|
US5179080A
(en)
*
|
1989-08-31 |
1993-01-12 |
Clinical Homecare, Corp. |
Formulations containing growth hormone and nutritional supplements, and methods of treating malnutrition in chronic lung disease
|
|
US5576351A
(en)
*
|
1989-12-29 |
1996-11-19 |
Mcgaw, Inc. |
Use of arginine as an immunostimulator
|
|
US5286739A
(en)
*
|
1991-09-27 |
1994-02-15 |
Board Of Regents, University Of Texas System |
Parenteral formulations for the inhibition of systemic hypotension associated with nitric oxide production or endothelial derived relaxing factor
|
|
DE4134723C1
(th)
*
|
1991-10-21 |
1993-02-11 |
Pfrimmer Kabi Gmbh & Co Kg, 8520 Erlangen, De |
|
|
US5266685A
(en)
*
|
1992-05-05 |
1993-11-30 |
Grain Processing Corporation |
Non-bitter protein hydrolyzates
|
|
JPH06109286A
(ja)
*
|
1992-09-28 |
1994-04-19 |
Daikin Ind Ltd |
圧縮機の取付構造
|
|
US5292722A
(en)
*
|
1992-11-06 |
1994-03-08 |
Brigham And Women's Hospital |
Intravenous solution that diminishes body protein loss
|
|
WO1994016740A1
(en)
*
|
1993-01-29 |
1994-08-04 |
Brigham And Women's Hospital |
The use of nitric oxide-delivering compounds for the treatment or prevention of alcoholic liver injury
|
|
US5571783A
(en)
*
|
1993-03-09 |
1996-11-05 |
Clintec Nutrition Company |
Composition and method for treating patients with hepatic disease
|
|
US5449679A
(en)
*
|
1994-07-29 |
1995-09-12 |
Leonard; Robert J. |
Process and products for reducing biological fluid levels of a lipid soluble waste
|
|
US20040022827A1
(en)
*
|
1997-09-30 |
2004-02-05 |
Chugai Seiyaku Kabusiki Kaisha |
Remedy for hepatopathy
|
|
FR2800243B1
(fr)
*
|
1999-11-02 |
2002-01-18 |
Royal Canin Sa |
Composition alimentaire ou veterinaire pour carnivore domestique contenant de la tyrosine libre pour prevenir les anomalies de pigmentation du pelage
|
|
US20010014442A1
(en)
*
|
2000-02-09 |
2001-08-16 |
Morris James G. |
Essential constituent and method of use for maintaining hair coloration or reversing hair discoloration
|
|
KR20030070147A
(ko)
*
|
2001-01-30 |
2003-08-27 |
아지노모토 가부시키가이샤 |
염증성 질환 치료 예방제
|
|
JPWO2002074302A1
(ja)
*
|
2001-03-15 |
2005-07-14 |
独立行政法人理化学研究所 |
肝機能障害改善用アミノ酸組成物
|
|
US20020193342A1
(en)
*
|
2001-05-09 |
2002-12-19 |
Hamman John P. |
Modifying undesirable tastes
|
|
US20040219188A1
(en)
*
|
2003-05-02 |
2004-11-04 |
Comer Gail M. |
Composition and methods for nutritional management of patients with hepatic disease
|
|
US20070031534A1
(en)
*
|
2004-02-27 |
2007-02-08 |
Hajime Tsujimoto |
Pet food for reducing food allergy reactions
|
|
PT2153870E
(pt)
|
2004-11-26 |
2014-03-12 |
Ucl Business Plc |
Composições compreendendo ornitina e fenilacetato ou fenilbutirato para tratamento de encefalopatia hepática
|
|
JPWO2006061992A1
(ja)
*
|
2004-12-10 |
2008-06-05 |
味の素株式会社 |
肝疾患予防・治療用組成物
|
|
WO2006102451A2
(en)
*
|
2005-03-21 |
2006-09-28 |
Abbott Laboratories |
Amino acid composition for improving glucose tolerance
|
|
EA023051B1
(ru)
|
2009-04-03 |
2016-04-29 |
Осера Терапьютикс, Инк. |
Кристаллические формы фенилацетата l-орнитина и их применение
|
|
EP2799067B1
(en)
|
2009-06-08 |
2019-04-03 |
UCL Business PLC |
Treatment of brain inflammation using L-Ornithine Phenylacetate
|
|
BR112013008054B1
(pt)
|
2010-10-06 |
2019-04-09 |
Ocera Therapeutics, Inc. |
Composição e processo para produção de sal de acetato de fenil l-ornitina
|
|
US11730760B2
(en)
|
2011-04-01 |
2023-08-22 |
The Bioregentech Institute, Inc. |
Laser assisted wound healing protocol and system
|
|
US11389663B2
(en)
|
2011-04-01 |
2022-07-19 |
Bioregentech, Inc. |
Laser assisted wound healing protocol and system
|
|
US11745026B2
(en)
|
2011-04-01 |
2023-09-05 |
The Bioregentech Institute, Inc. |
Laser assisted wound healing protocol and system
|
|
AU2014254001B2
(en)
*
|
2013-04-16 |
2019-10-24 |
The Bioregentech Institute, Inc. |
Laser assisted periodontium and osseus regeneration protocol
|
|
BR112017010761B1
(pt)
|
2014-11-24 |
2022-10-18 |
Ucl Business Plc |
Tratamento de doenças associadas à ativação de célula estrelada hepática com o uso de terapias de redução de amônia
|
|
CA2995823A1
(en)
|
2015-08-18 |
2017-02-23 |
Ocera Therapeutics, Inc. |
Treatment and prevention of muscle loss using l-ornithine in combination with at least one of phenylacetate and phenylbutyrate
|
|
US11654293B2
(en)
|
2016-11-10 |
2023-05-23 |
The Bioregentech Institute, Inc. |
Laser assisted wound healing protocol and system
|
|
JOP20190146A1
(ar)
|
2016-12-19 |
2019-06-18 |
Axcella Health Inc |
تركيبات حمض أميني وطرق لمعالجة أمراض الكبد
|
|
JP7126520B2
(ja)
|
2017-05-11 |
2022-08-26 |
オセラ セラピューティクス， インコーポレイテッド |
Ｌ－オルニチンフェニルアセテートを製造する方法
|
|
JP7266581B2
(ja)
|
2017-08-14 |
2023-04-28 |
アクセラ・ヘルス・インコーポレイテッド |
肝疾患の治療のためのアミノ酸組成物
|
|
US10596136B2
(en)
|
2018-06-20 |
2020-03-24 |
Axcella Health Inc. |
Compositions and methods for the treatment of fat infiltration in muscle
|